Plain-English translation of NCT03011697 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study — a long-term tracking project where researchers collect and analyze health information from people hospitalized with valvular heart disease. The study is not testing a new medication or procedure; instead, it's gathering real-world data from patients in China to understand the current state of heart valve disease, including how often it occurs, what treatments doctors are using, and how patients fare over time.
Heart valve disease is becoming more common as people age, but doctors don't have clear information about how prevalent it is or how patients will do over time — especially in developing countries like China. Because valve disease progresses slowly, many people don't get diagnosed until serious symptoms appear. This study exists to fill that knowledge gap and help improve care and outcomes for future patients.
You likely qualify if…
You likely don't qualify if…
As a participant, you would share your medical history, hospital records, and information about your heart valve disease with the research team at the hospital. You would be followed over time so researchers can track how your condition changes and what treatments you receive. The study involves no new medications or procedures — only data collection from your existing medical care and periodic check-ins to monitor your health status.
AI-generated summary from trial data · Aug 9, 2026 · Not medical advice
China
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Enrollment target
~10,000 participants
Started
February 2017
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2021.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Liu Xianbao, MD
Second Affiliated Hospital, Zhejiang University, School of Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.